drugset / Trial / NCT00437437
A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this trial is to determine the effect of food versus a fasted state on single-dose pharmacokinetics of BMS-540215, the active metabolite of Brivanib alaninate
Timeline
- Start
- 2000-05
- Primary completion
- 2008-05
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivanib | Small molecule | 800 mg | Oral |